Article info

Download PDFPDF
Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Zealand

Authors

  1. Correspondence to Rebecca Larcombe, University of South Australia, Adelaide, Australia; rebecca.larcombe{at}sa.gov.au
View Full Text

Citation

Larcombe R, Coulthard K, Eaton V, et al
Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Zealand

Publication history

  • Received September 7, 2022
  • Accepted December 6, 2022
  • First published December 20, 2022.
Online issue publication 
June 21, 2024

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.